Market Overview

Benzinga's Top Downgrades

Related ABT
Market Wrap For April 21: S&P 500 Extends Winning Streak To Five Days, Dow & Nasdaq Also Positive
Company News for April 17, 2014 - Corporate Summary
Related LLTC
Linear Technology Beats on Q3 Earnings - Analyst Blog
Morgan Stanley Sees Growth in Core Markets as Intact for Linear Technology

Analysts at Raymond James downgraded Abbott Laboratories (NYSE: ABT) from “outperform” to “market perform.” Abbott's shares closed at $69.04 yesterday. Abbott's trailing-twelve-month ROA is 8.67%.

Analysts at Nomura downgraded Linear Technology (NASDAQ: LLTC) from “buy” to “neutral.” Linear Technology's shares closed at $32.22 yesterday. Linear Technology's PEG ratio is 4.54.

Analysts at Stephens downgraded Halliburton Company (NYSE: HAL) from “overweight” to “equal weight.” Halliburton's shares closed at $35.32 yesterday. Halliburton's trailing-twelve-month profit margin is 10.66%.

Goldman Sachs downgraded St. Jude Medical (NYSE: STJ) from “buy” to “neutral.” St. Jude Medical's shares closed at $40.85 yesterday. St. Jude Medical's trailing-twelve-month ROE is 17.25%.

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Most Popular

Related Articles (ABT + HAL)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free